Navigation Links
Americord Registry Becomes First Cord Blood Bank to Offer Placenta Preservation, Advancing Cord Blood Stem Cell Therapy Options
Date:10/19/2010

NEW YORK, Oct. 19 /PRNewswire/ -- Americord Registry announced its breakthrough placenta stem cell preservation process, the first of its kind, as a new and significantly more effective alternative to private cord blood stem cell banking. The new process, called Cord Plus, preserves up to ten times more stem cells from the placenta than is found on average in a unit of cord blood, which contains only enough stem cells to treat a patient weighing less than 65 pounds. As a result of this breakthrough, doctors may soon be able to cure substantially more people of sickle cell, leukemia, and other life threatening blood disorders.

Despite being the fastest growing stem cell therapy used therapeutically, "Cord blood has never developed into a practical treatment for adults because there are simply not enough stem cells in one unit of cord blood to transplant to an adult," said Children's Hospital & Research Center Oakland (Calif.) scientist Frans Kuypers, Ph.D., a leader in the area of placenta research. "The greater supply of stem cells in the placenta will likely increase the chance that an HLA (human leukocyte antigen) matched unit of stem cells engrafts, making stem cell transplants available to more people. The more stem cells, the bigger the chance of success," says Kuypers.

Stem cells harvested from cord blood, first introduced as a therapy in 1983, have been playing an important and growing role in the treatment of life-threatening blood diseases as an alternative to bone marrow stem cell treatment. The National Marrow Donor Program projects that there will be 10,000 cord blood transplants per year by 2015, up from 2,000 in 2006. Reasons for using cord blood and placenta derived stem cells over bone marrow include (i) it is more easily matched with a recipient, (ii) it is more readily available and (iii) there is a lower chance of graft-versus-host disease, a potentially life threatening condition.

According to Martin Smithmyer, the Company's President, "Cord Plus, with its significantly higher concentration of stem cells per unit of blood, could potentially surpass both umbilical cord blood stem cell therapy and bone marrow stem cell therapy, presently the most widely used form of therapy."

About Americord Registry:Americord Registry is the first cord blood bank to offer Cord Plus, or cryogenic placenta stem cell preservation. Americord focuses on the collection, processing, and storage of newborn stem cells from umbilical cord blood and the placenta for future medical or therapeutic use. Americord is registered with the FDA and the company's laboratory is accredited by the AABB. The company was founded in 2008 and is based in New York, with laboratories in Oregon and New Jersey. To learn more, visit: www.americordregistry.com. Contact: Americord Registry, LLCPhone: (866) 503-6005Fax: (646) 304-7051
'/>"/>

SOURCE Americord Registry
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioMarin Announces Roll-Out of National PKU Registry
2. CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries
3. Interim Analysis of Data from e-HEALING Registry of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented at AHA Scientific Sessions 2008
4. EMD Serono Launches Landmark Patient Registry for Egg Freezing
5. CAS Registers 40 Millionth Substance in CAS REGISTRY(SM)
6. my1HIE(sm) Implements WellCentive Registry
7. InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry. InspireMD Will Also Sponsor a Satellite Program Breakfast Meeting at the TCT Conference on September 24th 2009 in the Moscone Exhibition Center in San Francisco
8. Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the Worlds First Adaptive 128-slice CT Scanner
9. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
10. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMeds Peer-Reviewed Video Journal JoVE
11. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in Peer-Reviewed Video Journal JoVE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):